(Getty Images) In a study that kept in touch with more than 500 women cancer survivors for an average of six years, nearly half continued to experience chemotherapy-induced peripheral neuropathy and a heightened risk of falling. The findings, published in the Journal of Clinical Oncology, challenge the widely held assumption that chemotherapy-induced neuropathy will mostly cause no serious long-term effects. “Many cancer survivors are told these chemo-related symptoms will eventually go away. Our study found that’s … Read More
Posts Tagged ‘falling’
Men with prostate cancer became more vulnerable to falls if they used androgen deprivation therapy, and the heightened risk of falling persisted for more than a year after ending therapy, a study has revealed.
Years after completing treatment, nearly half of women cancer survivors continued to experience chemotherapy-induced peripheral neuropathy in a new study that tracked more than 500 survivors. Those with neuropathy had worse physical functioning and a significantly higher risk of falls, the researchers reported this week at the American Society of Clinical Oncology Cancer Survivorship Symposium in San Francisco.